Clean Science & Technology has announced a significant milestone with the commencement of commercial production of hydroquinone and catechol at its manufacturing facilities. This development marks an important expansion in the company's specialty chemical manufacturing capabilities and reinforces its commitment to supporting India's import substitution goals.

Production Milestone

Clean Science & Technology has successfully started commercial production of two critical chemical compounds that serve various industrial applications. The following table outlines the key details of this production milestone:

Import Substitution Impact

The commencement of hydroquinone and catechol production represents a strategic contribution to India's import substitution initiatives. These specialty chemicals are essential components in various industrial processes, and domestic production helps reduce reliance on imported materials. The company's entry into manufacturing these compounds strengthens the domestic supply chain for critical chemical intermediates.

Market Position Enhancement

This production launch is expected to enhance Clean Science & Technology's market share in the specialty chemicals sector. The addition of hydroquinone and catechol to the company's product portfolio diversifies its manufacturing capabilities and creates new revenue streams. The company's established manufacturing expertise positions it well to serve domestic demand for these specialty chemical products.

Strategic Significance

The successful start of commercial production demonstrates the company's ability to expand its manufacturing footprint in high-value specialty chemicals. This development aligns with the broader industry trend toward domestic manufacturing of critical chemical compounds and supports the company's growth strategy in the specialty chemicals market.

The commencement of hydroquinone and catechol production not only strengthens Clean Science & Technology's import substitution efforts but also expands its market presence in the specialty chemicals industry. This strategic move is expected to contribute to the company's growth and reinforce its position in the domestic chemical manufacturing sector.

Clean Science & Technology Limited has successfully completed its postal ballot process on December 16, 2025, with shareholders overwhelmingly approving all six proposed resolutions for board restructuring and leadership transition. The voting results demonstrate strong shareholder confidence in the company's governance reforms, with 79.40% of total shares participating in the remote e-voting process.

Postal Ballot Results Overview

The company received substantial shareholder participation during the remote e-voting period from November 17 to December 16, 2025. All resolutions secured the requisite majority, reflecting broad-based support for the proposed changes across all shareholder categories.

Board Restructuring Approved

Shareholders approved several key changes to the board composition with overwhelming support. Ms. Madhu Dubhashi's directorship will continue beyond her 75th birthday on February 6, 2026, until February 19, 2026. Mr. Keval Navinchandra Doshi secured re-appointment as Non-executive Independent Director for a second five-year term from February 6, 2026, to February 5, 2031.

Two new appointments were approved - Mr. Raj Kamal and Ms. Pallavi Gokhale, both for five-year terms from November 6, 2025, to November 5, 2030, as Non-executive Independent Directors.

Leadership Transition Confirmed

The company's planned leadership transition received strong shareholder endorsement across all categories:

Voting Process and Participation

The postal ballot was conducted under Regulation 44 of SEBI Listing Regulations, with Mr. Jayavant B. Bhave serving as the scrutinizer. The total number of members on record date (November 10, 2025) was 2,49,493, with significant participation across all shareholder categories.

These approved resolutions will reshape Clean Science and Technology's leadership structure for the coming years, ensuring continuity in governance while bringing fresh perspectives through new independent directors. The overwhelming shareholder support demonstrates confidence in the company's strategic direction and management capabilities in the specialty chemicals sector.